Genomtec has conducted an analysis of its rapid genetic tests that confirmed their effectiveness in detecting all known variants of the SARS-CoV-2 virus including the recently discovered Omicron variant.
Due to growing concerns on ability of IVD tests to recognize newly appearing SARS-CoV-2 variants, Genomtec conducted bioinformatic (in-silico) as well as the wet lab analysis of its products, Genomtec® SARS-CoV-2 EvaGreen® RT-LAMP CE-IVD Duo Kit (RT-LAMP Duo) and Genomtec® SARS-CoV-2 EvaGreen® Direct-RT-LAMP CE-IVD Kit (Direct).
Results of the analysis confirmed their reliability in recognition of SARS-CoV-2 variants mentioned on the WHO list, including recently discovered Omicron.
– Recognition of multiple variants by the RT-LAMP Duo and Direct Kit produced by Genomtec is important to ensure public health safety where accurate testing against multiple types of SARS-CoV-2 variants of concern is absolutely crucial in sustaining efforts against pandemic surveillance. – said Miron Tokarski, co-founder and CEO of Genomtec.
More in analytical report: Download >>
